Chimerix Aktie News & Nachrichten
[WKN: A1T65B]Realtimekurs
Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC.
Stocks in Action USA: Chimerix, Alaska Air und United Natural Foods.
Chimerix (CMRX) – Die Aktie des Biotechs verdreifacht sich nach FDA-Zulassungshoffnung für Dordaviprone!...
- ‹
- 1
- ›